R
Robin Munro
Researcher at Wishaw General Hospital
Publications - 11
Citations - 456
Robin Munro is an academic researcher from Wishaw General Hospital. The author has contributed to research in topics: Rheumatoid arthritis & Population. The author has an hindex of 8, co-authored 11 publications receiving 439 citations.
Papers
More filters
Journal ArticleDOI
Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study
TL;DR: Only patients with disease duration of up to two years have a longlasting improvement in their functional ability after starting intramuscular gold treatment, and patients with early RA have a larger reversible component to their HAQ.
Journal ArticleDOI
Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double‐blind placebo‐controlled MASCOT study
Hilary A Capell,Rajan Madhok,Duncan Porter,Robin Munro,Iain B. McInnes,John Hunter,M. M. Steven,Asad Zoma,E Morrison,Martin Sambrook,Fat Wui Poon,Rosemary Hampson,Fiona McDonald,Ann Tierney,Neil Henderson,Ian Ford +15 more
TL;DR: In this “true-to-life” study, an inexpensive combination of DMARDs proved more effective than monotherapy in patients with rheumatoid arthritis with a suboptimal response to SASP.
Journal ArticleDOI
Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial.
Duncan Porter,Jurgen van Melckebeke,James Dale,C. Martina Messow,Alex McConnachie,Andrew Walker,Robin Munro,John McLaren,Euan McRorie,Jon Packham,Christopher D. Buckley,John Harvie,Peter C. Taylor,Ernest Choy,Costantino Pitzalis,Iain B. McInnes +15 more
TL;DR: Initial treatment with rituximab is non-inferior to initial TNF inhibitor treatment in patients seropositive for rheumatoid arthritis and naive to treatment with biologicals, and is cost saving over 12 months.
Journal ArticleDOI
Closing the osteoporosis management gap in primary care: a secondary prevention of fracture programme.
TL;DR: Evaluated a simple means of identifying patients with osteoporosis, assess the current management gap in this high risk patient group and to enable initiation of treatment where appropriate, and confirmed prior fracture was confirmed to be a strong predictor of bone mineral density.
Journal ArticleDOI
Brief Report: Predicting Functional Disability: One-Year Results From the Scottish Early Rheumatoid Arthritis Inception Cohort.
Caroline Kronisch,David J. McLernon,James Dale,Caron Paterson,Stuart H. Ralston,David M. Reid,Ann Tierney,John Harvie,Neil McKay,Hilary Wilson,Robin Munro,Sarah Saunders,Ruth Richmond,Derek Baxter,Mike McMahon,Vinod Kumar,John McLaren,Stefan Siebert,Iain B. McInnes,Duncan Porter,Gary J. Macfarlane,Neil Basu +21 more
TL;DR: The Scottish Early Rheumatoid Arthritis (SERA) inception cohort is a multicenter, prospective study of patients with newly presenting RA or undifferentiated arthritis.